Early data shows Novartis' experimental radiopharma drug reduces tumor markers in patients with advanced prostate cancer Novartis says 40% of cancer R&D investments going toward radiopharma therapies ...
The uncle reigns supreme across India’s divides of religion, caste and language. He earns his radioactive confidence through ...